You are here

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy

Authors

  1. Correspondence to : Dr Alexander T Cohen, Department of Thrombosis and Haemostasis, Guy's and St Thomas’ Hospitals, Westminster Bridge Road, London SE1 7EH, UK; alexander.cohen{at}kcl.ac.uk
View Full Text

Citation

Granziera S, Cohen AT
Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy
BMJ Evidence-Based Medicine 2014;19:180.

Publication history

  • First published May 16, 2014.
Online issue publication 
September 15, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions